Australia's largest stock trading and investment forum Australia's #1 stock forum

IHL

Click for more information

0.00%

4.1¢ incannex healthcare limited

Rust. I take blame for Dolci being here. I value his charts and...

First 164 Last

Share
Profile

Follow
tossydog

552 Posts.

620

19/07/20

22:45

Post #: 45969312
Share

Originally posted by The ruster: ↑

Come on D ,

You don’t hold you have no sentiment . Do you realise that this stock is on the cusp of something very special . I have been involved in the market for thirty years and seen all sorts of charts double tops saucer and handle triple watches you can run an argument for anything .inhave also held this stock for a very long time from the outset .

The facts are that this company has several ground breaking trials in the pipeline and have been successful on the first stage of It’s first trial , the ARDS trial .It is an excellent start and potentially globally significant . It also has massively increased its sales .

Regardless of whether it retraces to close the gap which as andres has espoused it is not assured as you must look at all gaps in the context of their significance and the facts are some gaps do not fill .The fundamentals are such that the SP will go higher IMO in the short term and re rate as they progress their trials , so forget the short term analysis look at the big picture and fundamentals .

The Bod and the medical experts are excellent . Many people print and comments on charts and T/A and profess to know charts and draw lines . The charts are historical and it is very difficult to predict short term moves , all one can say is that the stock is trending up or down and in this stock it is trending up based on the short term MA and long term MA .

As we know stocks do not run up or down in a straight line and fibonacci principles apply so the SP will see saw as all stocks do on Its way up , however , as long as the fundamentals roll out as we expect they will , this stock will significantly rerate in time and all the analysis of historical data short term will not mean squat if they deliver what they set out in their strategy .

BTW in any event stocks that set double top footprints with solid newsflow and excellent fundamentals recover from them regardless of any short term double top they have printed . So IMO there are no absolutes and generalised references to charts and other stocks and their charts do not apply . If IHL deliver positive news on any one of these trials ( and it has a stage 1 ards success already ) they will be rerated to $200-$300 m MC on any one of them being successful IMO . They are an IP / Big Pharma business and we need to allow them time to deliver . Patience is required here . It is not an easy task to build a Big Pharma business .

I have confidence that we will see this stock in the 20s in the short term as it progresses its strategy based on the newsflow we know is coming IMO .

Expand

Rust. I take blame for Dolci being here. I value his charts and asked him to take a look a couple weeks back. At that point he was positive. He doesn't have an agenda. I hope he is wrong this time around tho. I also agree that the market has not understood the magnitude of Friday's and the value to the business. I stand by my valuation of 20c on oil sales & now additional 20c on potential from positive results on Friday. I believe we are a 35-40c company at present trading at 7c!!!

IHL Price at posting: 7.0¢ Sentiment: Buy Disclosure: Held
10 Upvote

2 Great analysis

Reply

Top Stories

End of FY is a time to juggle wins, losses and capital gains taxes

Eurozone-based companies find new ways to secure a regional lithium supply

SS1

Sun Silver submits US$60M Silver Paste Funding Application to US DoE

Time for retail therapy buying in the shopping Scentre for hot stocks

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

There are more pages in this discussion • 26 more messages in this thread...

First 164 Last

Add IHL (ASX) to my watchlist